Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in Alpha-synuclein Models of Parkinson's and Lewy Body Diseases

Overview

Journal J Neurosci

Specialty Neurology

Date 2009 Oct 30

PMID 19864570

Citations 326

Authors

Brian Spencer

Rewati Potkar

Margarita Trejo

Edward Rockenstein

Christina Patrick

Ryan Gindi

Anthony Adame

Tony Wyss-Coray

Eliezer Masliah

Affiliations

Soon will be listed here.

Abstract

Accumulation of the synaptic protein alpha-synuclein (alpha-syn) is a hallmark of Parkinson's disease (PD) and Lewy body disease (LBD), a heterogeneous group of disorders with dementia and parkinsonism, where Alzheimer's disease and PD interact. Accumulation of alpha-syn in these patients might be associated with alterations in the autophagy pathway. Therefore, we postulate that delivery of beclin 1, a regulator of the autophagy pathway, might constitute a strategy toward developing a therapy for LBD/PD. Overexpression of alpha-syn from lentivirus transduction in a neuronal cell line resulted in lysosomal accumulation and alterations in autophagy. Coexpression of beclin 1 activated autophagy, reduced accumulation of alpha-syn, and ameliorated associated neuritic alterations. The effects of beclin 1 overexpression on LC3 and alpha-syn accumulation were partially blocked by 3-MA and completely blocked by bafilomycin A1. In contrast, rapamycin enhanced the effects of beclin 1. To evaluate the potential effects of activating autophagy in vivo, a lentivirus expressing beclin 1 was delivered to the brain of a alpha-syn transgenic mouse. Neuropathological analysis demonstrated that beclin 1 injections ameliorated the synaptic and dendritic pathology in the tg mice and reduced the accumulation of alpha-syn in the limbic system without any significant deleterious effects. This was accompanied by enhanced lysosomal activation and reduced alterations in the autophagy pathway. Thus, beclin 1 plays an important role in the intracellular degradation of alpha-syn either directly or indirectly through the autophagy pathway and may present a novel therapeutic target for LBD/PD.

Citing Articles

Canonical and noncanonical autophagy: involvement in Parkinson's disease.

Sakurai M, Kuwahara T Front Cell Dev Biol. 2025; 13:1518991.

PMID: 39949604 PMC: 11821624. DOI: 10.3389/fcell.2025.1518991.

TFE3-mediated neuroprotection: Clearance of aggregated α-synuclein and accumulated mitochondria in the AAV-α-synuclein model of Parkinson's disease.

He X, Chen M, Fan Y, Wu B, Dong Z Genes Dis. 2025; 12(2):101429.

PMID: 39759118 PMC: 11697191. DOI: 10.1016/j.gendis.2024.101429.

Therapeutic Potential of MCC950 in Restoring Autophagy and Cognitive Function in STZ-Induced Rat Model of Alzheimer's Disease.

Naeem A, Waseem A, Khan M, Robertson A, Raza S Mol Neurobiol. 2024; .

PMID: 39702834 DOI: 10.1007/s12035-024-04662-y.

An update on immune-based alpha-synuclein trials in Parkinson's disease.

Alfaidi M, Barker R, Kuan W J Neurol. 2024; 272(1):21.

PMID: 39666171 PMC: 11638298. DOI: 10.1007/s00415-024-12770-x.

α-Synuclein pathology as a target in neurodegenerative diseases.

Park H, Kam T, Dawson V, Dawson T Nat Rev Neurol. 2024; 21(1):32-47.

PMID: 39609631 DOI: 10.1038/s41582-024-01043-w.

References

Nakajima T, Takauchi S, Ohara K, Kokai M, Nishii R, Maeda S . Alpha-synuclein-positive structures induced in leupeptin-infused rats. Brain Res. 2005; 1040(1-2):73-80. DOI: 10.1016/j.brainres.2005.01.099. View

Trojanowski J, Lee V . Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol. 1998; 55(2):151-2. DOI: 10.1001/archneur.55.2.151. View

Bar-On P, Crews L, Koob A, Mizuno H, Adame A, Spencer B . Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease. J Neurochem. 2008; 105(5):1656-67. PMC: 2822545. DOI: 10.1111/j.1471-4159.2008.05254.x. View

Takacs-Vellai K, Vellai T, Puoti A, Passannante M, Wicky C, Streit A . Inactivation of the autophagy gene bec-1 triggers apoptotic cell death in C. elegans. Curr Biol. 2005; 15(16):1513-7. DOI: 10.1016/j.cub.2005.07.035. View

Furuya N, Yu J, Byfield M, Pattingre S, Levine B . The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy. 2006; 1(1):46-52. DOI: 10.4161/auto.1.1.1542. View

Cuervo A . Autophagy: in sickness and in health. Trends Cell Biol. 2004; 14(2):70-7. DOI: 10.1016/j.tcb.2003.12.002. View

Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

Fimia G, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R . Ambra1 regulates autophagy and development of the nervous system. Nature. 2007; 447(7148):1121-5. DOI: 10.1038/nature05925. View

10.

Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E . Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). J Neurosci Res. 2001; 66(4):573-82. DOI: 10.1002/jnr.1247. View

11.

King M, Hands S, Hafiz F, Mizushima N, Tolkovsky A, Wyttenbach A . Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol Pharmacol. 2008; 73(4):1052-63. DOI: 10.1124/mol.107.043398. View

12.

Liang X, Kleeman L, Jiang H, Gordon G, Goldman J, Berry G . Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 1998; 72(11):8586-96. PMC: 110269. DOI: 10.1128/JVI.72.11.8586-8596.1998. View

13.

Tsigelny I, Bar-On P, Sharikov Y, Crews L, Hashimoto M, Miller M . Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J. 2007; 274(7):1862-77. DOI: 10.1111/j.1742-4658.2007.05733.x. View

14.

Marr R, Rockenstein E, Mukherjee A, Kindy M, Hersh L, Gage F . Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003; 23(6):1992-6. PMC: 6742010. View

15.

Wang X, Proud C . The mTOR pathway in the control of protein synthesis. Physiology (Bethesda). 2006; 21:362-9. DOI: 10.1152/physiol.00024.2006. View

16.

Varkonyi J, Rosenbaum H, Baumann N, MacKenzie J, Simon Z, Aharon-Peretz J . Gaucher disease associated with parkinsonism: four further case reports. Am J Med Genet A. 2003; 116A(4):348-51. DOI: 10.1002/ajmg.a.10028. View

17.

Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H . NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett. 1998; 239(1):45-8. DOI: 10.1016/s0304-3940(97)00891-4. View

18.

Nixon R, Wegiel J, Kumar A, Yu W, Peterhoff C, Cataldo A . Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005; 64(2):113-22. DOI: 10.1093/jnen/64.2.113. View

19.

McKeith I . Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin. 2000; 18(4):865-902. DOI: 10.1016/s0733-8619(05)70230-9. View

20.

Williams A, Jahreiss L, Sarkar S, Saiki S, Menzies F, Ravikumar B . Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol. 2006; 76:89-101. DOI: 10.1016/S0070-2153(06)76003-3. View